ES2169150T3 - Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios. - Google Patents

Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.

Info

Publication number
ES2169150T3
ES2169150T3 ES95931734T ES95931734T ES2169150T3 ES 2169150 T3 ES2169150 T3 ES 2169150T3 ES 95931734 T ES95931734 T ES 95931734T ES 95931734 T ES95931734 T ES 95931734T ES 2169150 T3 ES2169150 T3 ES 2169150T3
Authority
ES
Spain
Prior art keywords
carbon atoms
rent
ramified
hydrogen
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95931734T
Other languages
English (en)
Inventor
Michael Wiard Scherz
John Michael Janusz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vanderbilt University
Original Assignee
Vanderbilt University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vanderbilt University filed Critical Vanderbilt University
Application granted granted Critical
Publication of ES2169150T3 publication Critical patent/ES2169150T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

UN COMPUESTO DE ESTRUCTURA (A), DONDE (A) W ES -C(X'')-NRR'' O NR-C(X'')R''; (B) X Y X'' SON, INDEPENDIENTEMENTE, O O S; (C) CADA Y ES, INDEPENDIENTEMENTE, HIDROGENO, O ALCANILO CICLICO, RAMIFICADO O LINEAL DE ENTRE 1 A APROX. 3 ATOMOS DE CARBONO, O LOS DOS Y''S ESTAN UNIDOS, FORMANDO UN ANILLO ALCANILO QUE TIENE DE 3 A 7 ATOMOS DE CARBONO; (D) Z ES ALQUILO CICLICO O RAMIFICADO Y NO SUSTITUIDO, O FENILO SUSTITUIDO CON ALCANILO, O BENCILO, TENIENDO Z ENTRE 3 Y APROX. 10 ATOMOS DISTINTOS DEL HIDROGENO; (E) R SE SELECCIONA ENTRE HIDROGENO, ALQUILO LINEAL O RAMIFICADO CON ENTRE 1 Y APROX. 6 ATOMOS DE CARBONO, Y ALQUILO CICLICO QUE CONSTA DE ENTRE 3 Y 6 ATOMOS DE CARBONO; Y (F) R'' SE SELECCIONA ENTRE HIDROGENO, HIDROXI, ALQUILO O ALCOXI, LINEAL O RAMIFICADO, CON ENTRE 1 Y 6 ATOMOS DE CARBONO, Y ALQUILO CICLICO CON ENTRE 3 Y 7 ATOMOS DE CARBONO. SE DESCRIBEN ASIMISMO COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN DICHOS COMPUESTOS, Y METODOS DE TRATAMIENTO DE LA INFLAMACION Y DEL DOLOR, UTILIZANDO DICHOS COMPUESTOS.
ES95931734T 1994-09-07 1995-09-06 Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios. Expired - Lifetime ES2169150T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30145694A 1994-09-07 1994-09-07

Publications (1)

Publication Number Publication Date
ES2169150T3 true ES2169150T3 (es) 2002-07-01

Family

ID=23163447

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95931734T Expired - Lifetime ES2169150T3 (es) 1994-09-07 1995-09-06 Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.

Country Status (15)

Country Link
US (1) US5684002A (es)
EP (1) EP0779886B1 (es)
JP (1) JPH10505089A (es)
KR (1) KR100249542B1 (es)
CN (1) CN1183126C (es)
AT (1) ATE210125T1 (es)
AU (1) AU682281B2 (es)
BR (1) BR9508901A (es)
CA (1) CA2199128C (es)
DE (1) DE69524428T2 (es)
DK (1) DK0779886T3 (es)
ES (1) ES2169150T3 (es)
MX (1) MX9701819A (es)
NZ (1) NZ292782A (es)
WO (1) WO1996007651A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684041A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5821250A (en) * 1996-02-01 1998-10-13 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5686471A (en) * 1996-02-01 1997-11-11 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5684031A (en) * 1996-02-01 1997-11-04 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5672620A (en) * 1996-02-01 1997-09-30 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5618835A (en) * 1996-02-01 1997-04-08 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
US5985930A (en) * 1996-11-21 1999-11-16 Pasinetti; Giulio M. Treatment of neurodegenerative conditions with nimesulide
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
HRP20130638T1 (en) 2003-06-26 2013-08-31 Takeda Pharmaceutical Company Limited Cannabinoid receptor modulator
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
US8440832B2 (en) * 2007-07-13 2013-05-14 Board Of Regents, The University Of Texas System Heterocyclic modulators of cannabinoid receptors
WO2009012227A1 (en) * 2007-07-13 2009-01-22 Board Of Regents, The University Of Texas System Hydrazone modulators of cannabinoid receptors
US9394267B2 (en) 2007-07-13 2016-07-19 The Cleveland Clinic Foundation Heterocyclic modulators of cannabinoid receptors
US9079854B2 (en) 2007-07-13 2015-07-14 The Cleveland Clinic Foundation Hydrazone modulators of cannabinoid receptors
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
JP2015530360A (ja) 2012-07-13 2015-10-15 ザ クリーブランド クリニック ファウンデーションＴｈｅ Ｃｌｅｖｅｌａｎｄ ＣｌｉｎｉｃＦｏｕｎｄａｔｉｏｎ 神経保護ｃｂ２受容体アゴニスト
KR101592560B1 (ko) * 2013-06-21 2016-02-05 제주대학교 산학협력단 신규 플라보노이드 및 그 용도
CN114133948A (zh) * 2021-12-29 2022-03-04 江苏三吉利化工股份有限公司 一种利用呋喃酚焦油制备橡胶油的方法
CN117624095B (zh) * 2023-11-28 2024-09-13 皖南医学院第一附属医院（皖南医学院弋矶山医院） 一种新型手性二氢苯并呋喃酰胺的合成方法及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758838A (fr) * 1969-11-13 1971-05-12 Geigy Ag J R Esters d'acides carboxyliques heterocyliques et medicaments renfermant de telles substances
JPS6031829B2 (ja) * 1975-06-26 1985-07-24 ウェルファイド株式会社 アミノアルコ−ル誘導体の製造法
FR2332010A1 (fr) * 1975-11-18 1977-06-17 Continental Pharma Amino-alcool heterocyclique, son sel et son procede de preparation
JPS6019305B2 (ja) * 1976-07-02 1985-05-15 ウェルファイド株式会社 ジヒドロベンゾフラン誘導体
JPS603305B2 (ja) * 1976-12-27 1985-01-26 エーザイ株式会社 ２，３―ジハイドロベンゾフラン誘導体
US4130666A (en) * 1977-05-16 1978-12-19 Riker Laboratories, Inc. Anti-inflammatory method
IT1093805B (it) * 1978-01-31 1985-07-26 Erba Carlo Spa Derivati del 2h-benzofuran-3-one e procedimento per la loro preparazione
DE3110009A1 (de) * 1981-03-11 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue benzofuran-derivate, ihre herstellung und verwendung
FI842738L (fi) * 1983-07-14 1985-01-15 Syntex Inc Aroylbenzofuran- och benzotiofenaettik- och propionsyror.
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
JPS61158976A (ja) * 1984-12-28 1986-07-18 Shionogi & Co Ltd ベンゾフランおよびベンゾチオフエン誘導体
US4708966A (en) * 1986-06-27 1987-11-24 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
US4849428A (en) * 1987-11-23 1989-07-18 The Procter & Gamble Company Cyclic anti-inflammatory derivatives of di-tert-butylphenol compounds, compositions and use
IL88674A0 (en) * 1987-12-18 1989-07-31 Norwich Eaton Pharma Preparation of certain substituted aromatic compounds
JPH07121933B2 (ja) * 1988-03-28 1995-12-25 キッセイ薬品工業株式会社 ジヒドロベンゾフラノン誘導体
GB9322781D0 (en) * 1993-11-04 1993-12-22 Roussel Lab Ltd Aromatic amides

Also Published As

Publication number Publication date
KR100249542B1 (ko) 2000-04-01
DE69524428T2 (de) 2002-05-23
EP0779886B1 (en) 2001-12-05
CA2199128A1 (en) 1996-03-14
MX9701819A (es) 1997-06-28
WO1996007651A1 (en) 1996-03-14
AU3505995A (en) 1996-03-27
DK0779886T3 (da) 2002-03-11
ATE210125T1 (de) 2001-12-15
DE69524428D1 (de) 2002-01-17
EP0779886A1 (en) 1997-06-25
US5684002A (en) 1997-11-04
JPH10505089A (ja) 1998-05-19
CA2199128C (en) 2001-03-20
AU682281B2 (en) 1997-09-25
BR9508901A (pt) 1998-01-06
KR970705553A (ko) 1997-10-09
CN1157613A (zh) 1997-08-20
CN1183126C (zh) 2005-01-05
NZ292782A (en) 1999-02-25

Similar Documents

Publication Publication Date Title
ES2169150T3 (es) Compuestos a base de dihidrobenzofurano y compuestos relacionados utiles como agentes anti-inflamatorios.
ES2116594T3 (es) Ansamicinas biciclicas y su uso como agentes antitumorales.
ES2059207T3 (es) Procedimiento para la preparacion de derivados del taxano, nuevos derivados obtenidos y composiciones farmaceuticas que les contienen.
ES2052556T3 (es) Fungicidas.
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
ES2084702T3 (es) Imidazoles sustituidos utiles como inhibidores de la angiotensina ii.
DE59309786D1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ES2080739T3 (es) Nitro-compuestos insecticidamente activos.
MX9700249A (es) Compuestos ariltios como agentes antibacteriales yantivirales.
SE9504661D0 (sv) New compounds
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2167751T3 (es) Preparaciones de insulina conteniendo un halogenuro.
MX9207394A (es) Esteroides de 17-espirofuran-3'-ilideno.
ES2072946T3 (es) Isomeros (+) de derivados de endoeteno/endoetano-epoximorfinano como agentes antitusivos.
ES2120145T3 (es) Compuestos bi-aromaticos acetilenados con grupo adamantilo, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2058191T3 (es) Acidos 2-fenil-4-quinolincarboxilicos substituidos.
ES2042556T3 (es) N,n'-diacilhidrazinas n-sustituidas, n'-sustituidas insecticidas.
ES2116612T3 (es) Nuevas bis-naftalimidas para el tratamiento del cancer.
BR9709556A (pt) Dihidrobenzopirano e compostos a ele relacionados úteis como agentes antiflamatórios
ES2184774T3 (es) Bifenil-2,2'-diil-bis-difenilfosfinas halogenadas, su preparacion y empleo.
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
ES2074249T3 (es) Compuesto tetra-n-glicidilo y mezclas reticulables del mismo.
ES2029799T3 (es) Derivados de 2,5,6,7 tetranor-4,8-inter-m-fenilen pg12.
ES2038176T3 (es) Un procedimiento para la preparacion de derivados del naftaleno.
ES2127263T3 (es) Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 779886

Country of ref document: ES